Vaxart Inc (VXRT)
0.6584
-0.05
(-7.23%)
USD |
NASDAQ |
Apr 25, 16:00
0.7067
+0.05
(+7.34%)
After-Hours: 20:00
Vaxart Total Assets (Quarterly): 91.83M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 91.83M |
September 30, 2023 | 105.64M |
June 30, 2023 | 122.65M |
March 31, 2023 | 129.85M |
December 31, 2022 | 153.85M |
September 30, 2022 | 175.31M |
June 30, 2022 | 181.45M |
March 31, 2022 | 200.38M |
December 31, 2021 | 221.17M |
September 30, 2021 | 241.14M |
June 30, 2021 | 228.84M |
March 31, 2021 | 205.87M |
December 31, 2020 | 152.58M |
September 30, 2020 | 154.71M |
June 30, 2020 | 64.19M |
March 31, 2020 | 52.56M |
December 31, 2019 | 37.03M |
September 30, 2019 | 42.70M |
June 30, 2019 | 37.25M |
March 31, 2019 | 36.31M |
December 31, 2018 | 35.23M |
September 30, 2018 | 40.64M |
June 30, 2018 | 47.76M |
March 31, 2018 | 56.54M |
December 31, 2017 | 32.60M |
Date | Value |
---|---|
September 30, 2017 | 34.70M |
June 30, 2017 | 40.10M |
March 31, 2017 | 46.70M |
December 31, 2016 | 56.50M |
September 30, 2016 | 63.10M |
June 30, 2016 | 72.70M |
March 31, 2016 | 61.90M |
December 31, 2015 | 64.20M |
September 30, 2015 | 71.00M |
June 30, 2015 | 79.40M |
March 31, 2015 | 88.80M |
December 31, 2014 | 93.40M |
September 30, 2014 | 97.30M |
June 30, 2014 | 114.00M |
March 31, 2014 | 120.50M |
December 31, 2013 | 82.70M |
September 30, 2013 | 79.00M |
June 30, 2013 | 85.80M |
March 31, 2013 | 94.84M |
December 31, 2012 | 96.18M |
September 30, 2012 | 66.51M |
June 30, 2012 | 92.95M |
March 31, 2012 | 95.24M |
December 31, 2011 | 97.96M |
September 30, 2011 | 104.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
37.03M
Minimum
Dec 2019
241.14M
Maximum
Sep 2021
136.79M
Average
152.58M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
Novavax Inc | 1.797B |
aTyr Pharma Inc | 120.65M |
Allogene Therapeutics Inc | 642.84M |
AIM ImmunoTech Inc | 19.38M |
Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 34.02M |
Shareholders Equity (Quarterly) | 57.80M |
Current Ratio | 3.318 |